As the p53 signaling pathway was of significant influence in the regulation of tumor progression [20], it was inferred that C2CD4A might promote the CRC growth by repressing the p53 signaling pathway based on our preliminary results. This evidence concerns the gene TP53 and colorectal carcinoma.